-
1
Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
Published 2022-04-01Subjects: Get full text
Article -
2
HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine
Published 2022-03-01Subjects: Get full text
Article -
3
-
4
Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients
Published 2023-03-01Subjects: Get full text
Article -
5
-
6
Incidence of adverse events of the Covid-19 vaccine in a population of kidney transplant recipients
Published 2024-06-01Subjects: Get full text
Article -
7
-
8
-
9
Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave
Published 2023-06-01Subjects: Get full text
Article -
10
New-onset chilblains in close temporal association to mRNA-1273 vaccination
Published 2021-06-01Subjects: Get full text
Article -
11
Six-month longitudinal immune kinetics after mRNA-1273 vaccination: Correlation of peak antibody response with long-term, cross-reactive immunity
Published 2023-01-01Subjects: Get full text
Article -
12
Diversity and inclusion in clinical trials: Evolution throughout the development of an mRNA COVID-19 vaccine
Published 2023-04-01Subjects: Get full text
Article -
13
Acquired hemophilia A (AHA) due to anti‐SARS‐CoV‐2 vaccination: A systematic review
Published 2023-05-01Subjects: Get full text
Article -
14
Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV
Published 2024-08-01Subjects: Get full text
Article -
15
Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report
Published 2021-10-01Subjects: Get full text
Article -
16
Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?
Published 2022-06-01Subjects: Get full text
Article -
17
Characteristics and outcomes of adverse events after COVID‐19 vaccination
Published 2021-10-01Subjects: Get full text
Article -
18
Side Effects of mRNA-Based COVID-19 Vaccines among Young Adults (18–30 Years Old): An Independent Post-Marketing Study
Published 2021-10-01Subjects: Get full text
Article -
19
Effectiveness of BNT162b2 and mRNA-1273 Vaccines against COVID-19 Infection: A Meta-Analysis of Test-Negative Design Studies
Published 2022-03-01Subjects: Get full text
Article -
20